Bahrain approves Pfizer/BioNTech COVID-19 vaccine use


By ELydf
  • World
  • Saturday, 05 Dec 2020

MANAMA, Dec. 4 (Xinhua) -- Bahrain's health regulator on Friday announced the authorization of emergency use of the Pfizer/BioNTech COVID-19 vaccine.

"Bahrain has approved the emergency use of Pfizer/BioNTech COVID-19 vaccine that will be used for high risk groups," said the National Health Regulatory Authority (NHRA).

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

France identifies first case of new mpox variant, AFP reports
North Korea's Kim oversees successful test of new hypersonic missile
Meta appoints 3 new board members
On anniversary of US Capitol attack, Proud Boys ex-leader asks Trump for pardon
Major winter storm sweeps across U.S., causing travel disruptions
2nd LD Writethru: Louisiana reports U.S. 1st human death from bird flu
US says anti-ISIS operation in Iraq kills coalition soldier
U.S. stocks close mixed
1st LD: Louisiana reports U.S. 1st human death from bird flu
Urgent: Louisiana reports U.S. 1st human death from bird flu

Others Also Read